Discovery of sulfonamide resistance genes in deep groundwater below Patna, IndiaShow others and affiliations
2024 (English)In: Environmental Pollution, ISSN 0269-7491, E-ISSN 1873-6424, Vol. 356, article id 124205Article in journal (Refereed) Published
Abstract [en]
Global usage of pharmaceuticals has led to the proliferation of bacteria that are resistant to antimicrobial treatments, creating a substantial public health challenge. Here, we investigate the emergence of sulfonamide resistance genes in groundwater and surface water in Patna, a rapidly developing city in Bihar, India. We report the first quantification of three sulfonamide resistance genes (sulI, sulII and sulIII) in groundwater (12-107 m in depth) in India. The mean relative abundance of gene copies was found to be sulI (2.4 x 10(-2) copies/16S rRNA gene) > sulII (5.4 x 10(-3) copies/16S rRNA gene) > sulIII (2.4 x 10(-3) copies/16S rRNA gene) in groundwater (n = 15) and surface water (n = 3). A comparison between antimicrobial resistance (AMR) genes and wastewater indicators, particularly tryptophan:fulvic-like fluorescence, suggests that wastewater was associated with AMR gene prevalence. Urban drainage channels, containing hospital and domestic wastes, are likely a substantial source of antimicrobial resistance in groundwater and surface water, including the Ganges (Ganga) River. This study is a reference point for decision-makers in the fight against antimicrobial resistance because it quantifies and determines potential sources of AMR genes in Indian groundwater.
Place, publisher, year, edition, pages
Elsevier BV , 2024. Vol. 356, article id 124205
Keywords [en]
Antimicrobial resistance genes, Sulfonamides, Water contamination, Rapidly developing city, Wastewater
National Category
Microbiology
Identifiers
URN: urn:nbn:se:kth:diva-350157DOI: 10.1016/j.envpol.2024.124205ISI: 001254953900001PubMedID: 38797351Scopus ID: 2-s2.0-85194577782OAI: oai:DiVA.org:kth-350157DiVA, id: diva2:1885398
Note
QC 20240723
2024-07-232024-07-232024-07-23Bibliographically approved